X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (213082) 213082
Conference Proceeding (6743) 6743
Newspaper Article (2615) 2615
Book Chapter (1828) 1828
Dissertation (1147) 1147
Book / eBook (637) 637
Newsletter (522) 522
Magazine Article (516) 516
Publication (370) 370
Trade Publication Article (261) 261
Web Resource (222) 222
Paper (82) 82
Report (75) 75
Government Document (51) 51
Book Review (33) 33
Standard (19) 19
Journal / eJournal (12) 12
Streaming Video (10) 10
Reference (6) 6
Electronic Resource (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79260) 79260
aggregation (78641) 78641
animals (37240) 37240
male (35225) 35225
female (29707) 29707
platelet aggregation - drug effects (21111) 21111
middle aged (19552) 19552
platelet aggregation inhibitors - therapeutic use (18702) 18702
platelet aggregation (17428) 17428
biochemistry & molecular biology (16345) 16345
aged (15558) 15558
analysis (15367) 15367
adult (14683) 14683
chemistry, physical (14373) 14373
chemistry, multidisciplinary (13587) 13587
hematology (10769) 10769
proteins (10077) 10077
cardiac & cardiovascular systems (9445) 9445
platelet aggregation inhibitors - pharmacology (9342) 9342
pharmacology & pharmacy (9308) 9308
mice (9033) 9033
peripheral vascular disease (9013) 9013
blood platelets - drug effects (8998) 8998
materials science, multidisciplinary (8718) 8718
rats (8586) 8586
research (8524) 8524
risk factors (8340) 8340
aspirin (8262) 8262
fluorescence (8157) 8157
time factors (8113) 8113
kinetics (8079) 8079
blood platelets - metabolism (7678) 7678
agglomeration (7565) 7565
treatment outcome (7555) 7555
platelet aggregation inhibitors - administration & dosage (7543) 7543
nanoparticles (7434) 7434
ticlopidine - analogs & derivatives (7344) 7344
aspirin - therapeutic use (7041) 7041
cell aggregation (6962) 6962
protein (6604) 6604
cell biology (6556) 6556
in vitro techniques (6455) 6455
platelet aggregation inhibitors - adverse effects (6449) 6449
clopidogrel (6420) 6420
protein aggregation (6338) 6338
platelets (6137) 6137
aggregation-induced emission (5928) 5928
biophysics (5718) 5718
thrombosis (5665) 5665
blood platelets (5623) 5623
activation (5432) 5432
polymer science (5420) 5420
blood platelets - physiology (5325) 5325
dose-response relationship, drug (5241) 5241
platelet-aggregation (5188) 5188
chemistry (5174) 5174
binding (5017) 5017
stability (4972) 4972
disease (4948) 4948
inhibition (4924) 4924
neurosciences (4892) 4892
temperature (4751) 4751
risk (4750) 4750
behavior (4624) 4624
multidisciplinary sciences (4622) 4622
ticlopidine - therapeutic use (4585) 4585
adenosine diphosphate - pharmacology (4548) 4548
cells, cultured (4537) 4537
in-vitro (4458) 4458
drug therapy, combination (4405) 4405
fester zustand (4339) 4339
polymers (4334) 4334
rabbits (4287) 4287
alzheimers-disease (4237) 4237
engineering, chemical (4230) 4230
aged, 80 and over (4223) 4223
solid-condition-of-aggregation (4214) 4214
anticoagulants - therapeutic use (4190) 4190
studies (4184) 4184
water (4133) 4133
medicine, general & internal (4098) 4098
nanoscience & nanotechnology (4013) 4013
amino acid sequence (3958) 3958
expression (3956) 3956
ecology (3865) 3865
cells (3847) 3847
adsorption (3823) 3823
mechanism (3815) 3815
usage (3781) 3781
protein binding (3714) 3714
dynamics (3652) 3652
aspirin - administration & dosage (3612) 3612
growth (3556) 3556
protein folding (3546) 3546
percutaneous coronary intervention (3534) 3534
abridged index medicus (3528) 3528
surgery (3516) 3516
molecular sequence data (3514) 3514
chemistry, applied (3507) 3507
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (137) 137
Mathematical Sciences - Stacks (115) 115
Online Resources - Online (110) 110
Robarts - Stacks (26) 26
UofT at Mississauga - Stacks (24) 24
Collection Dvlpm't (Acquisitions) - Closed Orders (19) 19
Collection Dvlpm't (Acquisitions) - Vendor file (19) 19
UTL at Downsview - May be requested (14) 14
Mathematical Sciences - Missing (11) 11
Physics - Stacks (11) 11
Engineering & Comp. Sci. - Stacks (7) 7
UofT at Scarborough - Stacks (7) 7
Chemistry (A D Allen) - Stacks (6) 6
Earth Sciences (Noranda) - Stacks (3) 3
Mathematical Sciences - Course Reserves (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Gerstein Science - Bindery (2) 2
Gerstein Science - Periodical Stacks (2) 2
Mathematical Sciences - Bindery (2) 2
New College (Ivey) - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Business (Joseph L Rotman) - Stacks (1) 1
Faculty of Information - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Map & Data - Data Reference (1) 1
OISE - Stacks (1) 1
Robarts - Government Pubs (1) 1
University Archives - Archives (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (215682) 215682
Japanese (3729) 3729
German (2601) 2601
Russian (2489) 2489
French (1831) 1831
Chinese (1721) 1721
Spanish (1024) 1024
Italian (750) 750
Portuguese (510) 510
Polish (414) 414
Korean (228) 228
Czech (167) 167
Dutch (118) 118
Hungarian (99) 99
Turkish (86) 86
Danish (73) 73
Swedish (63) 63
Ukrainian (49) 49
Croatian (38) 38
Norwegian (38) 38
Hebrew (37) 37
Serbian (32) 32
Romanian (31) 31
Slovak (31) 31
Bulgarian (20) 20
Lithuanian (19) 19
Finnish (18) 18
Arabic (14) 14
Indonesian (8) 8
Persian (6) 6
Slovenian (5) 5
Icelandic (4) 4
Malay (4) 4
Bosnian (3) 3
Vietnamese (2) 2
Afrikaans (1) 1
Breton (1) 1
Catalan (1) 1
Estonian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2009, Volume 53, Issue 10, pp. 849 - 856
Objectives The aim of this prospective trial was to assess whether platelet reactivity to clopidogrel assessed with multiple electrode platelet aggregometry... 
Cardiovascular | Internal Medicine | clopidogrel | whole blood aggregometry | stent thrombosis | platelet aggregation | ADVERSE CARDIOVASCULAR EVENTS | PERCUTANEOUS CORONARY INTERVENTION | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | IMPLANTATION | PREDICTORS | RESISTANCE | BARE-METAL | ANTAGONISTS | AGGREGOMETRY | Prospective Studies | Platelet Function Tests - methods | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Kaplan-Meier Estimate | Male | Thrombosis - epidemiology | Coronary Artery Disease - mortality | Electric Impedance | Ticlopidine - analogs & derivatives | Drug-Eluting Stents - adverse effects | Electrodes | Coronary Artery Disease - therapy | Point-of-Care Systems | Thrombosis - etiology | Ticlopidine - adverse effects | Platelet Aggregation Inhibitors - pharmacology | Female | Platelet Function Tests - instrumentation | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Coenzymes | Vasodilators | Adenosine diphosphate | Coronary heart disease | Thrombosis | Stent (Surgery) | Blood clot | Aggregation | Disease transmission | Blood platelets | Analysis | Adenosine triphosphatase | Drug therapy | Intervention | Anticoagulants | Aspirin | Heart attacks | Medical imaging | Cardiovascular disease | Studies | Confidence intervals | Coronary vessels | Acute coronary syndromes | Stents | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Chemistry – A European Journal, ISSN 0947-6539, 11/2015, Volume 21, Issue 48, pp. 17459 - 17465
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2008, Volume 51, Issue 3, pp. 256 - 260
Journal Article
2012, ISBN 1439841802, xiii, 304
Book
The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 12, pp. 1238 - 1251
In this large clinical trial, aspirin plus extended-release dipyridamole was found to have an efficacy similar to that of clopidogrel in the prevention of... 
ACTIVE CONTROLLED-TRIALS | HIGH-RISK PATIENTS | TICLOPIDINE | TRANSIENT ISCHEMIC ATTACK | DOUBLE-BLIND | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ARTERIAL ORIGIN ESPRIT | CEREBRAL-ISCHEMIA | UMCG Approved | NON-INFERIORITY TRIALS | ISSUES | MEDICINE, GENERAL & INTERNAL | PLACEBO | DESIGN | WARFARIN | REGIMENS | Myocardial Infarction - epidemiology | Benzoates - therapeutic use | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Vascular Diseases - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Dipyridamole - adverse effects | Female | Stroke - epidemiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Dipyridamole - therapeutic use | Benzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Brain Ischemia - epidemiology | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Ischemia - prevention & control | Factor Analysis, Statistical | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Stroke (Disease) | Aspirin | Usage | Care and treatment | Dipyridamole | Clopidogrel | Health aspects | Stroke | Index Medicus | Abridged Index Medicus | Recurrence | Brain Ischemia | Benzimidazoles | Follow-Up Studies | Neurons and Cognition | Cognition | Hemorrhage | Drug Delivery Systems | Life Sciences | Angiotensin II Type 1 Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Vascular Diseases | Mental Status Schedule | Retrospective Studies | Severity of Illness Index | Disability Evaluation | Benzoates | Drug Administration Schedule | International Cooperation | Ticlopidine | Myocardial Infarction | Platelet Aggregation Inhibitors | Santé publique et épidémiologie | Original | Dipyridamole/adverse effects/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Recurrence/prevention & control | Benzoates/therapeutic use | Brain Ischemia/epidemiology/prevention & control | MEDICIN OCH HÄLSOVETENSKAP | Platelet Aggregation Inhibitors/administration & dosage/adverse | Combination | MEDICAL AND HEALTH SCIENCES | Aspirin/administration & dosage/adverse effects | Myocardial Infarction/epidemiology | Factor Analysis | Benzimidazoles/therapeutic use | Drug Therapy | Ticlopidine/adverse effects/analogs & derivatives/therapeutic use | effects/therapeutic use | Vascular Diseases/mortality | Hemorrhage/chemically induced | Stroke/drug therapy/epidemiology/prevention & control | Statistical | Kaplan-Meiers Estimate
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 4, pp. 354 - 362
The antiplatelet drug clopidogrel requires activation by cytochrome P-450 (CYP) enzymes. This study shows that CYP polymorphisms that reduce clopidogrel... 
VARIABILITY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | PHARMACOKINETICS | STENT THROMBOSIS | INCREASED RISK | PLATELET INHIBITION | PRASUGREL | PHARMACODYNAMICS | INDIVIDUAL RESPONSIVENESS | ATHEROTHROMBOTIC EVENTS | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Area Under Curve | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Male | Cardiovascular Diseases - genetics | Angioplasty, Balloon, Coronary | Ticlopidine - adverse effects | Ticlopidine - metabolism | Cardiovascular Diseases - epidemiology | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - metabolism | Platelet Aggregation Inhibitors - therapeutic use | Stents | Platelet Aggregation Inhibitors - adverse effects | Genotype | Thrombosis - epidemiology | Combined Modality Therapy | Ticlopidine - analogs & derivatives | Polymorphism, Genetic | Randomized Controlled Trials as Topic | Cytochrome P-450 CYP2C19 | Acute Coronary Syndrome - therapy | Heterozygote | Thrombosis - genetics | Mutation | Usage | Genetic variation | Cytochrome P-450 | Physiological aspects | Causes of | Clopidogrel | Cardiovascular diseases | Health aspects | Risk factors | Studies | Cardiovascular disease | Heart attacks | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
ATOPAXAR | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | EFFICACY | SAFETY | TOLERABILITY | DOUBLE-BLIND | PRASUGREL | LESSONS | ANTAGONISTS | ASPIRIN | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Computer Science | Medical Imaging
Journal Article
Annual review of biochemistry, ISSN 0066-4154, 6/2017, Volume 86, Issue 1, pp. 27 - 68
Peptides and proteins have been found to possess an inherent tendency to convert from their native functional states into intractable amyloid aggregates. This... 
amyloidosis | quality control | protein aggregation | protein homeostasis | conformational diseases | chaperones | functional amyloid | Protein aggregation | Quality control | Functional amyloid | Amyloidosis | Chaperones | Protein homeostasis | Conformational diseases | FIBRIL FORMATION | NUCLEATED CONFORMATIONAL CONVERSION | SOLID-STATE NMR | STOP-CODON MUTATION | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | FAMILIAL BRITISH DEMENTIA | ALPHA-SYNUCLEIN AGGREGATION | BETA PRECURSOR PROTEIN | APOLIPOPROTEIN AII GENE | HUMAN PRION PROTEIN | Proteostasis Deficiencies - metabolism | Molecular Chaperones - metabolism | History, 21st Century | Parkinson Disease - history | Humans | Proteostasis Deficiencies - history | Protein Aggregation, Pathological - history | Drugs, Investigational | Parkinson Disease - drug therapy | Amyloid - chemistry | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 2 - history | Molecular Targeted Therapy | Alzheimer Disease - pathology | Amyloid - metabolism | Protein Aggregation, Pathological - pathology | Protein Aggregation, Pathological - prevention & control | Parkinson Disease - metabolism | Immunoglobulin Light-chain Amyloidosis | Amyloid - genetics | Alzheimer Disease - history | Parkinson Disease - pathology | Amyloidosis - pathology | Amyloidosis - history | Gene Expression Regulation | Molecular Chaperones - genetics | Proteostasis Deficiencies - pathology | Alzheimer Disease - drug therapy | Amyloidosis - drug therapy | Protein Folding | Proteostasis Deficiencies - prevention & control | Alzheimer Disease - metabolism | Protein Conformation | Diabetes Mellitus, Type 2 - pathology | Proteostasis Deficiencies - drug therapy | Diabetes Mellitus, Type 2 - drug therapy | Amyloidosis - metabolism | Protein Aggregation, Pathological - metabolism | Physiological aspects | Development and progression | Genetic aspects | Protein folding | Amyloid beta-protein
Journal Article